Nephrology Service, Hospital Privado Universitario de Córdoba, Córdoba 5000, Argentina.
Graduate Career in Nephrology, Instituto Universitario de Ciencias Biomédicas de Córdoba (IUCBC), Córdoba 5000, Argentina.
Nutrients. 2023 Feb 28;15(5):1233. doi: 10.3390/nu15051233.
There is no consensus on the best equation to estimate glomerular filtration rate (eGFR) in obese patients (OP). Objective: to evaluate the performance of the current equations and the new Argentinian Equation ("AE") to estimate GFR in OP. Two validation samples were used: internal (IVS, using 10-fold cross-validation) and temporary (TVS). OP whose GFR was measured (mGFR) with clearance of iothalamate between 2007/2017 (IVS, = 189) and 2018/2019 (TVS, = 26) were included. To evaluate the performance of the equations we used: bias (difference between eGFR and mGFR), P30 (percentage of estimates within ±30% of mGFR), Pearson's correlation (r) and percentage of correct classification (%CC) according to the stages of CKD. The median age was 50 years. Sixty percent had grade I obesity (G1-Ob), 25.1% G2-Ob and 14.9% G3-Ob, with a wide range in mGFR (5.6-173.1 mL/min/1.73 m). In the IVS, AE obtained a higher P30 (85.2%), r (0.86) and %CC (74.4%), with lower bias (-0.4 mL/min/1.73 m). In the TVS, AE obtained a higher P30 (88.5%), r (0.89) and %CC (84.6%). The performance of all equations was reduced in G3-Ob, but AE was the only one that obtained a P30 > 80% in all degrees. AE obtained better overall performance to estimate GFR in OP and could be useful in this population. Conclusions from this study may not be generalizable to all populations of obese patients since they were derived from a study in a single center with a very specific ethnic mixed population.
对于肥胖患者(OP),目前尚无关于肾小球滤过率(eGFR)最佳估算方程的共识。目的:评估目前的方程和新的阿根廷方程(“AE”)在肥胖患者中估算 GFR 的性能。使用了两个验证样本:内部验证样本(IVS,使用 10 倍交叉验证)和临时验证样本(TVS)。纳入 2007/2017 年(IVS,n = 189)和 2018/2019 年(TVS,n = 26)使用碘海醇清除法测量 GFR(mGFR)的 OP。为了评估方程的性能,我们使用了以下指标:偏差(eGFR 与 mGFR 之间的差异)、P30(估计值在 mGFR 的 ±30%范围内的百分比)、皮尔逊相关系数(r)和根据 CKD 分期的正确分类百分比(%CC)。中位年龄为 50 岁。60%的患者为 I 级肥胖(G1-Ob),25.1%为 G2-Ob,14.9%为 G3-Ob,mGFR 范围很广(5.6-173.1 mL/min/1.73 m)。在 IVS 中,AE 获得了更高的 P30(85.2%)、r(0.86)和%CC(74.4%),偏差更低(-0.4 mL/min/1.73 m)。在 TVS 中,AE 获得了更高的 P30(88.5%)、r(0.89)和%CC(84.6%)。所有方程在 G3-Ob 中的性能都有所降低,但 AE 是唯一一个在所有程度上都获得 P30 > 80%的方程。AE 在估算肥胖患者的 GFR 方面总体表现更好,可能在该人群中有用。但由于本研究来源于单中心研究,且混杂了特定的种族人群,因此本研究的结论可能不适用于所有肥胖患者人群。